CXCR4 and neoplasm: Secondly, miR-222 inhibits TAM chemotaxis by targeting C-X-C chemokine receptor type 4 (CXCR4) and C-X-C motif chemokine ligand 12 (CXCL12), which ultimately suppresses tumor growth in vivo.